Oculis Holding AG (OCS) Current Assets (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Current Assets of $289.9 million in Q1 2026, up 5.86% quarter-over-quarter from $273.9 million in Q4 2025, and up 38.07% on a YoY basis from $210.0 million in Q1 2025.
Oculis Holding AG (OCS) Current Assets (2021 - 2026) Analysis & Trends
Oculis Holding AG's Current Assets history runs 6 years deep, the most recent figure standing at $289.9 million for Q1 2026.
- In Q1 2026, Current Assets rose 38.07% year-over-year to $289.9 million; the TTM figure through Mar 2026 stood at $289.9 million (up 38.07% YoY), while the FY2025 annual figure was $273.9 million, up 128.71% from the prior year.
- Current Assets was $289.9 million for Q1 2026 at Oculis Holding AG, up from $273.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $289.9 million in Q1 2026 to a low of $24.6 million in Q4 2022.
- Historically, Current Assets has averaged $157.8 million across 5 years, with a median of $135.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Current Assets tumbled 52.81% in 2022, then surged 363.75% in 2023.
- A 5-year view of Current Assets shows it stood at $24.6 million in 2022, then jumped by 363.75% to $113.9 million in 2023, then rose by 5.15% to $119.7 million in 2024, then jumped by 128.71% to $273.9 million in 2025, then gained by 5.86% to $289.9 million in 2026.
- The last three Current Assets figures came in at $289.9 million (Q1 2026), $273.9 million (Q4 2025), and $188.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 600.85 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 289.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289.93 Mn |
| Dec 31, 2025 | 273.87 Mn |
| Sep 30, 2025 | 188.65 Mn |
| Jun 30, 2025 | 200.75 Mn |
| Mar 31, 2025 | 209.98 Mn |
| Dec 31, 2024 | 119.74 Mn |
| Sep 30, 2024 | 128.68 Mn |
| Jun 30, 2024 | 137.82 Mn |
| Mar 31, 2024 | 97.89 Mn |
| Dec 31, 2023 | 113.88 Mn |
| Sep 30, 2023 | 130.76 Mn |
| Jun 30, 2023 | 134.98 Mn |
| Dec 31, 2022 | 24.56 Mn |
| Dec 31, 2021 | 52.04 Mn |